Wells Fargo analyst Christopher Carey maintained a Sell rating on Colgate-Palmolive (CL – Research Report) yesterday and set a price ...
Investor's Business Daily on MSN1d
Colgate-Palmolive Stock Earns RS Rating Upgrade
How Much Money To Invest Now. Is Colgate-Palmolive Stock A Buy? Colgate-Palmolive stock has climbed more than 5% past a 95.59 ...
RBC Capital analyst Nik Modi maintained a Hold rating on Colgate-Palmolive (CL – Research Report) on October 7 and set a price target of ...
Key Insights Given the large stake in the stock by institutions, Colgate-Palmolive's stock price might be vulnerable ...
On Monday, Colgate-Palmolive Company (CL) stock saw a decline, ending the day at $98.57 which represents a decrease of $-0.47 or -0.47% from the prior close of $99.04. The stock opened at $99.58 and ...
Ltd. gained 0.04 per cent to Rs 3714.25 in Thursday's trade. It hit a high of Rs 3759.65 and low of Rs 3708.75 during the ...
This was the stock's fifth consecutive day of losses.
This was the stock's fourth consecutive day of losses.
Jun-2024, promoters held 0.0 per cent stake in the company, while FIIs held 24.44 per cent and domestic institutional ...
On Wednesday, Colgate-Palmolive Company (CL) stock saw a decline, ending the day at $102.06 which represents a decrease of $-0.27 or -0.26% from the prior close of $102.33. The stock opened at $102.06 ...
EXCLUSIVE: Cannabis Companies Must 'Get More Juice From The Same Squeeze,' Says Cresco Labs CEO As Challenges Persist Charlie Bachtell, CEO of Cresco Labs, discusses the challenges of balancing ...